Urethral Cancer Clinical Trials

39 clinical trials for Urethral Cancer across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• DESTINY-PANTUMOUR04 — RECRUITING
• Integrated Cancer Repository for Cancer Research — RECRUITING
• 64Cu-GRIP B in Patients With Advanced Malignancies — RECRUITING · PHASE1
• A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest — RECRUITING · NA
• Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors — COMPLETED · PHASE1
• Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma — ACTIVE_NOT_RECRUITING
• Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant — ACTIVE_NOT_RECRUITING · PHASE2
• UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch — COMPLETED · NA
• Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function — COMPLETED · PHASE2
• Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract — COMPLETED · PHASE2
• Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium — COMPLETED · PHASE2
• Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium — COMPLETED · PHASE3
• Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer — COMPLETED · PHASE2
• Combination Chemotherapy in Treating Patients With Bladder Cancer — COMPLETED · PHASE3
• MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour — OTHER · PHASE1
• Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract — COMPLETED · PHASE2
• Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer — COMPLETED · PHASE2
• Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT) — COMPLETED · PHASE2
• Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants — COMPLETED
• Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium — COMPLETED · PHASE1
• Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma — OTHER · PHASE3
• S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract — TERMINATED · PHASE2
• Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium — COMPLETED · PHASE2
• Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium — COMPLETED · PHASE1
• Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer — COMPLETED · PHASE2
• Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not Responded to Treatment — COMPLETED · PHASE2
• Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer — OTHER · PHASE2
• Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer — COMPLETED · PHASE2
• Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer — COMPLETED · PHASE3
• Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium — COMPLETED · PHASE2
• S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium — COMPLETED · PHASE2
• S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium — COMPLETED · PHASE2
• S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium — TERMINATED · PHASE2
• S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy — COMPLETED · PHASE2
• Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium — COMPLETED · PHASE2
• S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract — COMPLETED · PHASE2
• Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract — COMPLETED · PHASE2
• SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract — COMPLETED · PHASE2

Refine this search